Epstein-Barr virus (EBV)-associated lymphomas are a known risk for immunosuppressed individuals.
Summary of Roundtable Discussion Meeting: Non-Human Primates to Assess Risk for EBV-Related Lymphomas in Humans.
Journal of Immunotoxicology, 2012
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Journal of Immunotoxicology, 2012
Epstein-Barr virus (EBV)-associated lymphomas are a known risk for immunosuppressed individuals.
Journal of Immunotoxicology, 2020
Currently, there is a multitude of CD3 bispecifics with different molecular designs and binding properties in preclinical and clinical development for the treatment of liquid or solid tumors. The key safety concerns with CD3 bispecifics are excessive release of cytokines, which may translate to potentially life-threating ...
Environmental and Molecular Mutagenesis, 2011
To view the full citation, click here.
Toxicological Sciences, 2006
Biomonitoring programs in the United States and Europe demonstrate the vast array of data that are publicly available for the evaluation of exposure trends, identification of susceptible populations, detection of emerging chemical risks, the conduct of epidemiology studies, and evaluation of risk reduction strategies.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2008
A meeting was convened so that users of three models for in vitro developmental toxicity (embryonic stem cells, whole embryo culture, and zebrafish) could share their experiences with each model, and explore the areas for improvement.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. (2016) 809: 1–15., 2016
Good cell culture practice and characterization of the cell lines used are of critical importance in in vitro genotoxicity testing. The objective of this initiative was to make continuously available stocks of the characterized isolates of the most frequently used mammalian cell lines in genotoxicity testing anywhere in the ...
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.